Global Healthy Living Foundation announces Louis Tharp to AIDS United's board of trustees

Co-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five Diagnostic Assays

ViiV Healthcare plans to develop N6LS

Newly Published Research Demonstrates Ability of Hologic's Assay to Detect Mycoplasma Genitalium, "the Silent Epidemic"

Johnson & Johnson to invest more than USD500m in next four years

US Food and Drug Administration Approves Descovy for HIV Pre-Exposure Prophylaxis

Gilead Sciences' Descovy granted US FDA approval

FDA approves Descovy for pre-exposure prophylaxis to prevent HIV infection

Celltrion to launch Temixys in US

Bavarian Nordic receives US FDA approval of JYNNEOS for prevention of smallpox and monkeypox disease in adults

US FDA approves Merck's HIV-1 drugs Pifeltro and Delstrigo

ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every Two Months

Signant Health names new clinical vice president, Internal Medicine

Ontario Drug Benefit Program to offer eligible HIV patients access to Gilead Sciences Canada's Biktarvy tablets

ViiV Healthcare reveals data from phase III TANGO study